logo
Plus   Neg
Share
Email

BTG FY Product Sales At Upper End Of Its Prior Outlook - Quick Facts

BTG plc (BTG.L) issued an update for the 12 months ended 31 March 2019, revealing product sales at the top end of the Board's view. Oncology and Vascular sales are in line with the Board's projected growth range of 15-17%. Pharmaceuticals recorded double-digit growth, ahead of the company's outlook of low single digit growth. Licensing revenues are broadly flat with previous year, the Group said.

BTG plc said its Board continues to expect that the acquisition of BTG by Boston Scientific unit, which remains subject to the satisfaction or waiver of certain conditions, to close around the middle of the calendar year 2019.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Alibaba is upgrading its intellectual property system using blockchain technology, according to local news outlet Sohu. Alibaba Platform Management expects this to benefit mainly small and medium-sized enterprises, brands and entrepreneurs. The technology will be fully implemented in September, and thereafter, the company intends to expand it to the field of digital copyright protection. Electronics retailer Best Buy Co., Inc. (BBY) reported Thursday a 27 percent increase in profit for the first quarter from last year, which was impacted by restructuring charges, and higher revenues. Both adjusted earnings per share and revenues for the quarter topped analysts' estimates. The company also provides guidance for the second quarter and reiterated its outlook for the full-year 2020. While reporting financial results for the second quarter on Thursday, Hormel Foods Corp. (HRL) lowered its earnings and net sales guidance for the full-year 2019. For fiscal 2019, the company now projects earnings in a range of $1.71 to $1.85 per share, and net sales between $9.70 billion and $10.20...
Follow RTT